期刊文献+

投药量对SPG膜乳化法制备载蛋白微球性质的影响 被引量:2

Effect of Theoretical Drug Loading on Morphology and Release of Protein Loaded Microspheres Fabricated by SPG Membrane Emulsification
原文传递
导出
摘要 目的采用SPG膜乳化法制备载牛血清白蛋白的聚乙二醇-聚乳酸聚乙醇酸(PEG-PLGA)微球,研究投药量对微球性质的影响。方法以包封率、载药量及粒径等为指标,评价PEG-PLGA微球的理化性质。采用扫描电镜观察微球的内外形态结构,并考察微球体外释药行为及吸水膨胀性能。结果随着投药量的增加,微球表面及内部孔洞增加,微球释药速率增快。投药量为75 mg时,实际载药量及吸水膨胀有最大值。结论不同投药量所得微球的内外形态在载蛋白PEG-PLGA微球的释放中发挥重要作用。 OBJECTIVE The influence of the theoretical drug loading on the physicochemical properties of the polyethylene glycol-poly lactic acid-co-glycolic acid( PEG-PLGA) microspheres loaded bovine serum albumin( BSA) fabricated by SPG membrane emulsification was investigated. METHODS Encapsulation efficiency,drug loading and particle size were used to evaluate the physicochemical properties of the microspheres. The surface and internal morphology of the microspheres were investigated by scanning electron microscopy. The release behaviors and the swelling of the microspheres were also systematically studied. RESULTS When the theoretical drug loading increased,the number of surface and internal pores increased,resulted in faster drug release. When the dosage was 75 mg,the microspheres showed highest encapsulation efficiency and swelling ratio. CONCLUSION The microspheres prepared with different theoretical drug loading shows different surface and internal morphology,which plays a significant role in in vitro release behaviors.
出处 《今日药学》 CAS 2017年第11期725-728,共4页 Pharmacy Today
基金 广东省医院药学研究基金(2017A18)
关键词 缓释微球 聚乙二醇-聚乳酸聚乙醇酸 蛋白药物 SPG膜乳化法 sustained-release microspheres polyethylene glycol-poly lactic acid-co-glycolic acid protein drug SPG membraneemulsification
  • 相关文献

参考文献4

二级参考文献29

  • 1陈丹,赵洁.适合于植物花器官的冰冻切片技术[J].武汉植物学研究,2005,23(3):285-290. 被引量:37
  • 2YANG Yiyan, CHUNG Taishung, NG Ngeeping.Morphology, drug distribution, and in vitro release profile of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method [ J ]. Biomaterials ,2001,22(3) :231-241.
  • 3KLOSE D, SIEPMANN F, ELKHARRAZ K, et al. How porosity and size affect the drug release mechanisms from PLGA-based micropartieles [ J ]. Int J Pharm, 2006, 314 (2) :198-206.
  • 4LEE J, OH Y J, LEE S K, et al. Facile control of porous structures of polymer microspheres using an osmotic agent for pulmonary delivery [ J ]. J Control Release, 2010, 146 (1) :61-67.
  • 5Felix Lanao R P, LEEUWENBURGH S C G,WOLKE J G C, et al. In vitro degradation rate of apatitic calcium phosphate cement with incorporated PLGA microspheres [ J] .Aeta Biomater,2011,7(9) :3459-3468.
  • 6CHENG Delin, GAO Huiehang, HAO Lijing, et al. Facile development of a hollow composite microsphere with porous surface for cell delivery [ J ] .Mat Lett, 2013,111 ( 15 ) : 238- 241.
  • 7DELPLACE C, THILLAYE du B O, SIEPMANN F, et al. PLGAs bearing carboxylated side chains: novel matrix formers with improved properties for controlled drug delivery[ J] .J Control Release ,2013,166(3) :256-267.
  • 8ANDERSON J M,SHIVE M S. Biodegradation and biocom- patibility of PLA and PLGA microspheres [ J ]. Adv Drug Deliv Rev,2012,64(Suppl) :72-82.
  • 9QI Feng, WU Jie, YANG Tingyuan, et al. Mechanistic studies for monodisperse exenatide-loaded PLGA microspheres prepared by different methods based on SPG membrane emulsification [ J 1. Acta Biomater, 2014,10 ( 8 ) : 4247-4256.
  • 10KLOSE D, SIEPMANN F,WILLART J F, et al. Drug release from PLGA-based microparticles : effects of the microparticle : bulk fluid ratio[J]. Int J Pharm,2010,383(1/2) :123-131.

共引文献12

同被引文献31

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部